Submit manuscript...
eISSN: 2469-2778

Hematology & Transfusion International Journal

Research Article Volume 5 Issue 6

Improved quality and number of platelet count in apheresis-platelet concentrate>Buffy coat-platelet concentrate & platelet rich plasma-platelet concentrate, assessed by study of quality parameters in 119 units of platelet concentrate

Mitul B Modi, Manasi P Trivedi, Sameer B Dalsaniya, Irappa Madabhavi, Trupti Patel, Dhaval Jetly

Department of Pathology, Gujarat Cancer & Research Institute, Ahmedabad, India

Correspondence: Mitul B Modi, PG Resident, Department of Pathology, Gujarat Cancer & Research Institute, Ahmedabad, India, Tel 919662010331

Received: March 28, 2017 | Published: December 29, 2017

Citation: Trivedi MP, Modi MB, Dalsaniya SB, et al. Improved quality and number of platelet count in apheresis-platelet concentrate>Buffy coat-platelet concentrate & platelet rich plasma-platelet concentrate, assessed by study of quality parameters in 119 units of platelet concentrate. Hematol Transfus Int J. 2017;5(6):335-337. DOI: 10.15406/htij.2017.05.00139

Download PDF

Abstract

Background: A successful transfusion requires whole blood to be separated into components that can be removed based on specific gravity via centrifugation. Platelet quality can then be determined using in vitro analysis of the following parameters: volume, swirling, platelet count (PLC), WBC count, and pH. This study was performed to assess the platelet concentrate (PC) quality obtained by three different methods as per the recommended quality norms at our blood bank.

Design: Random donor platelets by platelet rich plasma-platelet concentrate (PRP-PC), Buffy coat poor-platelet concentrate (BC-PC), and single donor platelets by Apheresis-PC (APH-PC) were prepared and examined. A total of 119units (58 BC-PC, 36 PRP-PC, and 25 APH-PC) were assessed using the following parameters: volume, swirling, PLC, and pH.

Results: The mean volume of PRP-PC, BC-PC and APH-PC was 73.04±4.35ml, 75.01±3.27ml and 272±2.98ml and ranged from 68-88ml, 55-82ml and 263-276ml, respectively. The mean PLC of PRP-PC, BC-PC, and APH-PC were 7.95±2.31×1010/unit, 66±2.29×1010/unit, and 4.19±0.45×1011/unit and ranged from 4-13.6×1010/unit, 5.4-15.4×1010/unit and 3-4.7×1011/unit, respectively. The mean pH was 6.23±0.15 (range: 6.0-6.8). No significant difference was observed among the three PC types. All units had a pH well above the recommended norm. PRP-PC and BC-PC units were comparable in terms of swirling, PLC per unit, and pH (Table 1).

Keywords: apheresis, quality parameters, platelet

Quality Parameters

PRP-PC

BC-PC

A-PC

Volume (ml)

73.04± 4.35

75.01± 3.27

272± 2.98

Swirling (Each day)

Present

Present

Present

PLC (4th day)

7.95± 2.31x 1010/unit

8.66 ± 2.29x 1010/unit

4.19 ± 0.45x 1011/unit

pH (5th day)

6-6.4

6.3-6.8

6-6.6

WBC Contamination

5.48 ± 3.75x 107/unit

4.30 ± 3.52x 107/unit

-

Culture

Sterile

Sterile

Sterile

Table 1 Parameters with quality

Abbreviations

PC, platelet concentrate; PRP-PC, platelet rich plasma-platelet concentrate; BC-PC, buffy coat poor-platelet concentrate; APH-PC, apheresis-PC; RDP, random donor platelets; SDPs, single donor platelets; PR, percentage recovery; CCI, corrected count increment

Introduction

Since Platelets were first identified in 1981, there has been continuous and accelerating progress in our basic understanding of platelet function and its utilization in various bleeding disorders. General improvement of the technique to separate platelets from whole blood and availability of plastic bags in blood banking revolutionized the field of component therapy. Platelet transfusions are the primary therapy for thrombocytopenia due to various causes. Thrombocytopenia may be due to qualitative defect, i.e. defect in platelet function or quantitative defect, i.e. decreased platelet count which can be seen in various hemato-oncological patients either due to primary disease or chemotherapy.1

Two types of platelet concentrates are available for transfusion; one which is the co-product of normal blood donation i.e. random donor platelets (RDP), (platelet rich plasma-platelet concentrate (PRP-PC) and buffy coat poor-platelet concentrate (BC-PC) and the other is single donor platelets (SDPs), (apheresis-PC,) collected from voluntary thrombocytapheresis donors with the help of an automated cell separator. The recommended shelf life of platelet concentrates in presently available platelet storage bags is 5days at 22±2°C with continuous agitation. The platelets undergo various storage changes starting from collection, processing to storage and the underlying conditions within the patients, which may affect the therapeutic benefit to the recipient.

The in vitro platelet quality can be assessed by using certain parameters (swirling, volume, platelet count and WBC count per bag and pH changes) and in vivo by using corrected count increment (CCI) and percentage recovery (PR) at 1hour and 20hours post transfusion which accesses the functional platelets in circulation. In this study we have analyzed the quality of different platelet concentrates prepared by different methods as per the recommended quality norms.

Material and methods

This study was conducted in the Blood bank of G.C.R.I. Ahmedabad, a total of 119 units of platelet concentrate were selected over the period of one year (june 2014 to May 2015) for our study (Table 2).2

PRP Platelets

36 units

Buffy Coat PC

58 units

Apheresis PC

25 units

 Table 2 No of units selected for study

Methods of preparation used

Platelet rich plasma platelet concentrate (PRP-PC): In PRP method, PRP is separated from whole blood by ‘Soft Spin’ centrifugation, then platelets are concentrated by ‘Hard Spin’ centrifugation and the supernatant plasma is subsequently removed.

Buffy coat poor platelets concentrate (BC-PC): In Buffy coat method, whole blood is first centrifuged at ‘Hard Spin’ with subsequent collection of Buffy coat. Buffy coat is then centrifuged at ‘Soft Spin’ to concentrate platelets leaving behind the red cells and white cells.

Single donor platelet (Apheresis-PC): In Apheresis method, apheresis is carried out in a continuous flow centrifugal device, in which single donor platelet is collected and rest of the components are rein fused back to the donor (Table 3).3

Method

Programme

Rpm

Rcf

Radius

Accel

Decel

Time (min)

Tem (‘C)

Product Obtained

BC- PC Penpol

1st Spin (Hard Spin)

3350

3726

29.7

8

2

9

22

LRAS, FFP

2nd Spin (Soft Spin)

780

202

29.7

6

2

6

22

Platelet Concentrate

BC-PC Fenwal

1st Spin (Hard Spin)

3880

4999

29.7

9

5

10

22

LRAS, FFP

2nd Spin (Soft Spin)

1100

402

29.7

7

4

6

22

Platelet Concentrate

PRP- PC

1st Spin (Soft Spin)

1800

1076

29.7

5

1

10

22

RAS obtained

2nd Spin (Hard Spin)

3250

3507

29.7

9

4

10

22

FFP, PRP obtained.

Apheress

By Amicus Cell Separator

Table 3 Methods and product obtained

Parameters

  1. Swirling
  2. Volume of platelet concentrate
  3. Platelet count
  4. WBC count*
  5. PH study
  6. Sterility

Calculation

Platelet count =platelet/cmm x 1000 x volume of PC (ml)

Volume of the concentrate= (Wt. of the full bag- Wt. of empty bag)/ Sp. Gravity

WBC Count= WBC/cmm x 1000 x volume of PC (ml)

(Platelet and WBC count is primarily measured (/cumm) in sysmex kx30 (3 part cbc analyzer)

The swirling was evaluated by examining the units against light and scored as:

  1. Score 0: Homogen turbid and is not changed with pressure.
  2. Score 1: Homogen swirling only in some part of the bag and is not clear.
  3. Score 2: Clear homogenic swirling in all part of the bag.
  4. Score 3: Very clear homogen swirling in all part of the bag.

Result

Concentrates were selected and more than 75% of each platelet Concentrate meets the criteria of quality that are comparable to the standard of WHO. The range of platelet count was 4-13.6 x1010/unit in PRP-PC 5.4-15.4 x1010/unit in Buffy coat-PC and 3-4.7 x1011 /unit in Aphaeresis-pc (Table 1,4 & 5).

Scoring

PRP-PC

BC-PC

Apheresis-PC

Total

n = 36

%age

n = 58

%age

n = 25

%age

n = 119

%age

5

18

50

19

32.7

17

68

54

45.4

4

12

33.34

28

48.3

6

24

46

38.6

3

5

13.8

8

13.8

2

8

15

12.6

2

1

2.8

3

5.2

-

-

4

3.4

1

-

-

-

-

-

-

-

-

Table 4 Parameters Scoring

S No

Quality Indicator

Benchmark

Result

1

Rejection with Donor History of drug (aspirin and other antiplatelet drugs)

100%

100%

2

Total Collection Time

8-10 minutes

100%

3

Number of times the temperature not maintained during transport blood from camp

0

0

4

Component separation time (from the time of collection)

Within 6 hrs

100%

5

Volume of platelet concentrate

50-70 ml in 75 % of the units

100%

6

PH of platelet concentrate

> 6 in 75% of the units

100%

7

Platelet Count in a unit(BC-PC)

> 6* 1010/ul in 75% of the units

100%

8

Platelet Count in a unit(PRP)

> 5.5* 1010/ul in 75% of the units

100%

9

Platelet Count in a unit(Apheresis)

> 3.5* 1011/ul in 75% of the units

100%

10

WBC Count in a unit(BC-PC)

< 5.5* 106/ul

100%

11

WBC Count in a unit (Apheresis)

< 5* 106/ul

100%

12

WBC Count in a unit(PRP-PC)

< 5.5*107/ul

13

Bacterial contamination by culture

Sterile (1 % of all units)

100%

Table 5 Quality Indicators for platelet concentrate

Conclusion

Evaluations of Quality indicators conclude that platelet concentrate prepared in GCRI Blood Bank meet all the criteria for quality aspects of platelets. PRP-PC and BC-PC units were comparable in terms of swirling, platelet count per unit and pH. As expected, we found WBC contamination to be less in BC-PC than PRP-PC units. Variation in volume was more in PRP-PC than BC-PC units and this suggests that further standardization is required for preparation of PRP-PC. As compared to the above two platelet concentrates, all the units of apheresis-PC fulfilled the desired quality control criteria of volume. Apheresis-PC units showed better swirling and platelet count than PRP-PCs and BC-PCs. All the platelet concentrate units had pH well above the recommended norm. Our study suggests though that the apheresis platelets are superior to PRP-PC and BC-PC in terms of platelet counts.

Thus, in developing countries apheresis platelets, because of their high cost and more technical expertise required may be recommended only in selected patients either when PRP-PC and BC-PC in adequate doses are not available in the inventory, or when HLA-matched platelet transfusions are indicated. Buffy coat Method is better than PRP method if we include the cost factor.

Acknowledgements

None.

Conflict of interest

The author declares no conflict of interest.

References

Creative Commons Attribution License

©2017 Trivedi, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.